SEC Form 4 · accession 0001061983-17-000063
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert I Blum
Officer — President & CEO · Director
Period of report
Nov 1, 2017
Accepted (ET)
Nov 3, 2017 · 8:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2017 | S | 500 | $13.10 | D | 70,180 | D | |
| Common Stock | Nov 1, 2017 | S | 100 | $13.15 | D | 70,080 | D | |
| Common Stock | Nov 1, 2017 | S | 200 | $13.375 | D | 69,880 | D | |
| Common Stock | Nov 1, 2017 | S | 1,100 | $13.40 | D | 68,780 | D | |
| Common Stock | Nov 1, 2017 | S | 100 | $13.425 | D | 68,680 | D | |
| Common Stock | Nov 1, 2017 | S | 200 | $13.55 | D | 68,480 | D | |
| Common Stock | Nov 1, 2017 | S | 100 | $13.575 | D | 68,380 | D | |
| Common Stock | Nov 1, 2017 | S | 1 | $13.5804 | D | 68,379 | D | |
| Common Stock | Nov 1, 2017 | S | 1,000 | $13.60 | D | 67,379 | D | |
| Common Stock | Nov 1, 2017 | S | 1,000 | $13.65 | D | 66,379 | D | |
| Common Stock | Nov 1, 2017 | S | 100 | $13.675 | D | 66,279 | D | |
| Common Stock | Nov 1, 2017 | S | 347 | $13.70 | D | 65,932 | D | |
| Common Stock | Nov 1, 2017 | S | 252 | $13.80 | D | 65,680 | D | |
| Common StockF2 | holding | — | — | — | 2,083 | I | by Trust 1 | |
| Common StockF3 | holding | — | — | — | 2,083 | I | by Trust 2 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017.
- F2Shares held by The Bridget Blum 2003 Irrevocable Trust.
- F3Shares held by The Brittany Blum 2003 Irrevocable Trust.